Article info
PDFCommentary
Nucleos(t)ide analogues in patients with chronic hepatitis B: to stop or not to stop?
- Correspondence to Prof. Dr Thomas Berg, Clinic and Polyclinic for Gastroenterology, Hepatology, Infectiology and Pneumology, Univeristy Hospital Leipzig, Liebigstr. 20; 04103 Leipzig, Germany; thomas.berg{at}medizin.uni-leipzig.de
Citation
Nucleos(t)ide analogues in patients with chronic hepatitis B: to stop or not to stop?
Publication history
- Received August 17, 2019
- Revised August 21, 2019
- Accepted August 22, 2019
- First published September 16, 2019.
Online issue publication
January 30, 2020
Article Versions
- Previous version (30 January 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.